Er-Kim Announces Exclusive Distribution Agreement with Ascen

BUCHAREST, Romania, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced it has entered into an exclusive distribution agreement

Related Keywords

Albania , Czech Republic , Lithuania , Hungary , Kosovo , Cyprus , Croatia , Bulgaria , Latvia , Turkey , Romania , Montenegro , United States , Poland , Macedonia , Estonia , Malta , Greece , Bucharest , Bucuresti , Serbia , Slovenia , Czechia , Rosalia Scampoli , J Clin Endocrinol , Ascendis Pharma , Mert Zorlular , Significant Health , Kim Pharmaceuticals , European Union , Danish Company Ascendis Pharmaas Nasdaq , Danish Company Ascendis Pharma , North Macedonia , Camilla Harder Hartvig , Executive Vice President , Chief Commercial , Endocrinology Rare Disease , Eastern Europe , Er Kim Pharmaceuticals , Height Trial , Flight Trial , Enlighten Trial , Flight Trials , Horm Res , Clin Endocrinol , Bone Miner , Life Improvements Achieved , Achondroplasia Treated , One Year , Press Release , Region ,